PMID- 22205661 OWN - NLM STAT- MEDLINE DCOM- 20120613 LR - 20211021 IS - 1556-679X (Electronic) IS - 1556-6811 (Print) IS - 1556-679X (Linking) VI - 19 IP - 3 DP - 2012 Mar TI - Effects of pretreating serum samples on the performance of a latex agglutination test for serodiagnosis of paracoccidioidomycosis. PG - 386-90 LID - 10.1128/CVI.05274-11 [doi] AB - Paracoccidioidomycosis (PCM) is a fungal disease caused by Paracoccidioides brasiliensis, and Brazil is one of the principal countries where it is endemic. Diagnosis is based on the observation of budding P. brasiliensis yeast in clinical specimens from patients; however, the sensitivity of the visualization of fungi is low, indicating that serological tests are used for early diagnosis. The double-immunodiffusion test (ID) is the "gold standard" test for serology in PCM, although the execution of this test requires the availability of laboratorial infrastructure. We report the improved performance of a latex agglutination test (LAT) by pretreating 30 serum samples from PCM patients and 71 controls (histoplasmosis and aspergillosis patients, patients with bacterial infections, and normal human sera) with a dilution buffer incubated at 37 degrees C for 30 min. The sensitivity and specificity of the LAT test in the nonpretreated samples were 73% and 79%, respectively. However, when samples were pretreated, the sensitivity and specificity of the test increased to 90%. In this study, we did not observe cross-reactivity with histoplasmosis patient sera, but some reactions to sera from patients with aspergillosis and bacterial infections were noted. Normal human sera were not reactive in our tests. These results indicate the need for the elimination of heterologous reactions so that we can adequately use this method for screening cases of PCM. FAU - Silveira-Gomes, Fabiola AU - Silveira-Gomes F AD - Science Biologic Institute, Federal University of Para, Belem, Para, Brazil. FAU - Marques-da-Silva, Silvia Helena AU - Marques-da-Silva SH LA - eng PT - Comparative Study PT - Evaluation Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20111228 PL - United States TA - Clin Vaccine Immunol JT - Clinical and vaccine immunology : CVI JID - 101252125 RN - 0 (Antibodies, Fungal) SB - IM MH - Adult MH - Aged MH - Antibodies, Fungal/*blood MH - Brazil MH - Cross Reactions MH - Female MH - Humans MH - Latex Fixation Tests/methods MH - Male MH - Middle Aged MH - Paracoccidioides/*immunology MH - Paracoccidioidomycosis/*diagnosis MH - Sensitivity and Specificity MH - Serologic Tests/methods MH - Serum/*immunology MH - Specimen Handling/*methods PMC - PMC3294624 EDAT- 2011/12/30 06:00 MHDA- 2012/06/14 06:00 PMCR- 2012/09/01 CRDT- 2011/12/30 06:00 PHST- 2011/12/30 06:00 [entrez] PHST- 2011/12/30 06:00 [pubmed] PHST- 2012/06/14 06:00 [medline] PHST- 2012/09/01 00:00 [pmc-release] AID - CVI.05274-11 [pii] AID - 05274-11 [pii] AID - 10.1128/CVI.05274-11 [doi] PST - ppublish SO - Clin Vaccine Immunol. 2012 Mar;19(3):386-90. doi: 10.1128/CVI.05274-11. Epub 2011 Dec 28.